ACE and COVID-19: It has been hypothesized that in the initial phase of SARS-CoV-2 infection, a RAS imbalance with increased activation of the classical RAS arm (i.e., renin/ACE/angiotensin II axis) leads to alterations in hemostasis and a hyperinflammatory state, triggering COVID-19 [9].